Impact of Mother Donor, Peripheral Blood Stem Cells and Measurable Residual Disease on Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Children with Acute Leukemia

By
Justin.choi
-
0
26
Investigators analyzed 144 acute leukemia haploidentical hematopoietic-cell transplantation using post-transplant cyclophosphamide pediatric recipients; median age was ten years.
[Bone Marrow Transplantation]
Abstract